GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Electromedical Technologies Inc (OTCPK:EMED) » Definitions » Earnings per Share (Diluted)

Electromedical Technologies (Electromedical Technologies) Earnings per Share (Diluted) : $-0.00 (TTM As of Dec. 2023)


View and export this data going back to 2019. Start your Free Trial

What is Electromedical Technologies Earnings per Share (Diluted)?

Electromedical Technologies's Earnings per Share (Diluted) for the three months ended in Dec. 2023 was $0.00. Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2023 was $-0.00.

Electromedical Technologies's EPS (Basic) for the three months ended in Dec. 2023 was $0.00. Its EPS (Basic) for the trailing twelve months (TTM) ended in Dec. 2023 was $-0.00.

Electromedical Technologies's EPS without NRI for the three months ended in Dec. 2023 was $0.00. Its EPS without NRI for the trailing twelve months (TTM) ended in Dec. 2023 was $-0.01.

During the past 3 years, the average EPS without NRIGrowth Rate was 64.60% per year.

During the past 5 years, Electromedical Technologies's highest 3-Year average EPS without NRI Growth Rate was 64.60% per year. The lowest was 39.60% per year. And the median was 52.10% per year.


Electromedical Technologies Earnings per Share (Diluted) Historical Data

The historical data trend for Electromedical Technologies's Earnings per Share (Diluted) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Electromedical Technologies Earnings per Share (Diluted) Chart

Electromedical Technologies Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23
Earnings per Share (Diluted)
-0.10 -0.20 -0.24 -0.03 -0.01

Electromedical Technologies Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Earnings per Share (Diluted) Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -0.01 - - - -

Competitive Comparison of Electromedical Technologies's Earnings per Share (Diluted)

For the Medical Devices subindustry, Electromedical Technologies's PE Ratio, along with its competitors' market caps and PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Electromedical Technologies's PE Ratio Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Electromedical Technologies's PE Ratio distribution charts can be found below:

* The bar in red indicates where Electromedical Technologies's PE Ratio falls into.



Electromedical Technologies Earnings per Share (Diluted) Calculation

Earnings Per Share (EPS) is the amount of earnings per outstanding share of the company's stock. In calculating earnings per share, the dividends of preferred stocks need to subtracted from the total net income first.

Electromedical Technologies's Earnings Per Share (Diluted) for the fiscal year that ended in Dec. 2023 is calculated as

Diluted Earnings Per Share (A: Dec. 2023 ) = (Net Income - Preferred Dividends) / Shares Outstanding (Diluted Average)
=(-2.641-0)/377.216
=-0.01

Electromedical Technologies's Earnings Per Share (Diluted) for the quarter that ended in Dec. 2023 is calculated as

Diluted Earnings Per Share (Q: Dec. 2023 )=(Net Income - Preferred Dividends / Shares Outstanding (Diluted Average)
=(-0.349-0)/464.597
=-0.00

Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $-0.00

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Companies also reported diluted shares in their financial reports. Diluted shares include the shares of convertibles or warrants outstanding.


Electromedical Technologies  (OTCPK:EMED) Earnings per Share (Diluted) Explanation

Earnings Per Share (EPS) is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists EPS without NRI, which better reflects the company's underlying performance.


Be Aware

Compared with Earnings per share, a company's cash flow is better indicator of the company's earnings power.

If a company's earnings per share is less than cash flow per share over long term, investors need to be cautious and find out why.


Electromedical Technologies Earnings per Share (Diluted) Related Terms

Thank you for viewing the detailed overview of Electromedical Technologies's Earnings per Share (Diluted) provided by GuruFocus.com. Please click on the following links to see related term pages.


Electromedical Technologies (Electromedical Technologies) Business Description

Traded in Other Exchanges
N/A
Address
16561 North 92nd Street, Suite 101, Scottsdale, AZ, USA, 85260
Electromedical Technologies Inc is a bioelectronics manufacturing company. It designs and develops simple-to-use bioelectronics therapy devices, which in major cases provide immediate and long-lasting pain relief across the broadest range of ailments. Its focuses on improving global wellness for people suffering from various painful conditions. It Develops and manufactures bioelectronics products.
Executives
Hymers Iii R. Leslie director 520 S GRAND AVENUE, STE 320, LOS ANGELES CA 90071
Lee Benson director PO BOX 41828, MESA AZ 41828
Donald J Steinberg 10 percent owner 3223 SUMAC ROAD, FALLBROOK CA 92028
Matthew Wolfson director, officer: CEO, CFO 16561 N. 92ND STREET, STE. 101, SCOTTSDALE AZ 85260